<DOC>
	<DOCNO>NCT00370110</DOCNO>
	<brief_summary>Itopride new compound already market Japan country Eastern Europe name Ganaton . It use treat symptom associate gastroparesis . Due inadequate gastric emptying , patient often symptoms bloat , nausea vomit follow ingestion meal . This randomize , parallel group , two dose double blind , placebo-controlled study evaluate effect itopride ( 100 mg 200 mg three time daily ) placebo gastric motor sensory function healthy volunteer .</brief_summary>
	<brief_title>Effects Itopride Gastric Motor Sensory Functions Healthy Volunteers</brief_title>
	<detailed_description>In order compare effect two itopride dos ( 100 mg 200 mg three time daily ) placebo gastric empty small bowel transit , gastric accommodation , postprandial symptom female male healthy volunteer , follow method , extensively use validated laboratory , use : Scintigraphic gastric empty solid small bowel transit ; single photon emission compute tomography measure gastric accommodation ; nutrient drink test measure maximum tolerate volume postprandial symptom . Based data acquire use method laboratory , sample size 15 subject per group provide 80 % power detect effect size 16 % primary endpoint study , change gastric volume ( postprandial - fasting ) . This magnitude change consider clinically relevant .</detailed_description>
	<criteria>1.Nonpregnant , nonbreastfeeding female 2.18 year age old 3.Body mass index 20 32 kg/m2 4.No alarm indicator clinical assessment ( weight loss 7 kg , bleeding , recent recurrent vomiting , progressive dysphagia ) . 5.No history suggestive small bowel obstruction 1 . Patients gastrointestinal symptom . Do fulfill criterion irritable bowel syndrome functional dyspepsia clinically 2 . Patients clinical diagnosis gastroparesis alternative underlying disease could responsible disturbed gastric function e.g . diabetes , postvagotomy , postfundoplication 3 . Abdominal surgery appendectomy , cholecystectomy , hysterectomy , caesarian section tubal ligation 4 . Positive symptom abridge bowel disease questionnaire 5 . Use medication may alter gastrointestinal motility include metoclopramide , domperidone , tegaserod ; acetaminophen ibuprofen allow 6 . Current use medication may interact study medication 7 . Patients take investigational medication within past 30 day 8 . Over counter medication ( except multivitamin ) within 7 day study 9 . Chronic gastrointestinal illness systemic disease could affect gastrointestinal motility control 10 . Known intolerance allergy egg , milk Ensure 11 . History chronic diarrhea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>